Kidney International Reports

Article	Citations
Collapsing Glomerulopathy in a Patient With COVID-19	225
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy	171
Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection	169
Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis	162
COVID-19 Vaccination and Glomerulonephritis	124
De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19	104
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2	99
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD	91
COVID-19–Associated Collapsing Glomerulopathy: An Emerging Entity	90
A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease	83
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy	81
Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)	80
Safety of Remdesivir in Patients With Acute Kidney Injury or CKD	72
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy	69
Preventing CKD in Developed Countries	68
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events	68
CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management	64
Roxadustat for CKD-related Anemia in Non-dialysis Patients	62
A Systematic Review of COVID-19 and Kidney Transplantation	62
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale	62
IgA Vasculitis With Nephritis (Henoch−Schönlein Purpura) in a COVID-19 Patient	59
Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance	58
Current and Investigational Therapeutics for Fabry Disease	58
Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney Disease	57
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations	55

Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy”	54
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events	54
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study	53
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients	52
Complement in Secondary Thrombotic Microangiopathy	52
SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease	51
Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era	51
Proteomic Analysis of Complement Proteins in Membranous Nephropathy	50
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine	44
Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City	44
COVID-19 in Patients on Maintenance Dialysis in the Paris Region	44
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors	43
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India	43
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19	42
Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis	42
Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients	40
Dialysis-Induced Cardiovascular and Multiorgan Morbidity	40
Surgical Management of Secondary Hyperparathyroidism	39
Rituximab in Membranous Nephropathy	39
Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy	37
Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients	37
Why Target the Gut to Treat IgA Nephropathy?	35
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD	34
COVID-19 Outbreak in a Large Hemodialysis Center in Lombardy, Italy	34
Transplantation for Primary Hyperoxaluria Type 1: Designing New Strategies in the Era of Promising Therapeutic Perspectives	34
Sepsis-Associated Acute Kidney Disease	34
Prediction of Short- and Long-Term Outcomes in Childhood Nephrotic Syndrome	33
Frailty in CKD and Transplantation	33
A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome	33
Polycystins, ADPKD, and Cardiovascular Disease	33
The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists	33
COVID-19 and the Renin-Angiotensin System	32
Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria	32
Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy	31
Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD	30
An Overview of Rickets in Children	30
Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease	30
Systematic Review and Meta-analysis of COVID-19 and Kidney Transplant Recipients, the South West London Kidney Transplant Network Experience	29
RETRACTED: Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis	29
Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS	29
Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations	29
Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action	29
Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort	28
Convolutional Neural Network Model for Intensive Care Unit Acute Kidney Injury Prediction	28
APOL1 Kidney-Risk Variants Induce Mitochondrial Fission	27
Determinants of the Evolution of Kidney Function With Age	27
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults	26
Low-Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis	26
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation	26
Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice	26

Attitudes and Practices of Australian Nephrologists Toward Implementation of Clinical Genomics	26
Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients	26
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19	26
Type IV Collagen Mutations in Familial IgA Nephropathy	25
Predialysis Care Trajectories of Patients With ESKD Starting Dialysis in Emergency in France	25
Biological Efficacy and Safety of Niacinamide in Patients With ADPKD	24
Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19	24
Deceased Donor Kidneys Utilization and Discard Rates During COVID-19 Pandemic in the United States	24
A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti–Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients	24
Health-Related Quality of Life in People Across the Spectrum of CKD	24
Nephrologists’ Perspectives on Gender Disparities in CKD and Dialysis	24
Uric Acid and Chronic Kidney Disease: Still More to Do	24
Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet–Biedl Syndrome	23
On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss	23
Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom	23
A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD	23
Letter regarding: “A Case of Gross Hematuria and IgA Nephropathy Flare-Up Following SARS-CoV-2 Vaccination”	23
The Crystalline Nephropathies	23
Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine	23
Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD	23
A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study	23
Renal Function Decline Under Therapy With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria	23
Mitochondrial Disease and the Kidney With a Special Focus on CoQ10 Deficiency	23
Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation	23
Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis	22
Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis	22
An Evaluation of Commonly Used Surrogate Baseline Creatinine Values to Classify AKI During Acute Infection	22
Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes	22
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France	22
Randomized Trial—PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving Hemodialysis	22
A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study	22
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19	22
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients	22
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial	22
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease	22
A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy	21
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients	21
Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients	21
Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	21
Current Management of Hyperkalemia in Patients on Dialysis	21
Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19	21
Prevalence and Associated Factors of Chronic Kidney Disease among Relatives of Hemodialysis Patients in Saudi Arabia	21
Impact of Deceased Donor Kidney Procurement Biopsy Technique on Histologic Accuracy	21
Phosphate Balance and CKD–Mineral Bone Disease	21
Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis	21
Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts	21
A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease	20
Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria	20
Low-Level Proteinuria in Systemic Lupus Erythematosus	20
Toxic Nephropathy Secondary to Chronic Mercury Poisoning: Clinical Characteristics and Outcomes	20
Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy	20
Urine Single-Cell RNA Sequencing in Focal Segmental Glomerulosclerosis Reveals Inflammatory Signatures	20
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality—The Boston Kidney Biopsy Cohort Study	20
Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza	20
POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS	20
Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation	20
Chronic Kidney Disease of Unknown Etiology in India: What Do We Know and Where We Need to Go	20
External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort	20
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria	20
Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era	20
Atypical Hemolytic and Uremic Syndrome Triggered by Infection With SARS-CoV2	20
Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis	20
Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation	20
Evaluation of Urinary Biomarkers of Proximal Tubular Injury, Inflammation, and Fibrosis in Patients With Albuminuric and Nonalbuminuric Diabetic Kidney Disease	20
High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health	20
Quality of Care for Acute Kidney Disease: Current Knowledge Gaps and Future Directions	19
A Precision Medicine Approach Uncovers a Unique Signature of Neutrophils in Patients With Brushite Kidney Stones	19
Immune-Complex Glomerulonephritis After COVID-19 Infection	19
Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome	19
A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes	19
Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries	19
The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome	19
Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys	19
The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey	19
Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease	18
A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders	18
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry	18
Central Venous Catheters for Hemodialysis—the Myth and the Evidence	18
A Systematic Review of Renal Functional Reserve in Adult Living Kidney Donors	18
A Systematic Review and Meta-Analysis of Diabetes During Pregnancy and Congenital Genitourinary Abnormalities	18

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers	18
Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)	18
The COVID-19 Pandemic Identifies Significant Global Inequities in Hemodialysis Care in Low and Lower-Middle Income Countries—An ISN/DOPPS Survey	18
Past, Present, and Future of Phosphate Management	18
Use of the Selective Cytopheretic Device in Critically Ill Children	18
Concurrent Antiglomerular Basement Membrane Nephritis and Antineutrophil Cytoplasmic Autoantibody–Mediated Glomerulonephritis After Second Dose of SARS-CoV-2 mRNA Vaccination	18
Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes	17
Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study	17
Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome	17
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort	17
Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort	17
Delivering Dialysis During the COVID-19 Outbreak: Strategies and Outcomes	17
Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19–Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center	17
Assessment of Plasma Oxalate Concentration in Patients With CKD	17
Assessing the Accuracy of ChatGPT on Core Questions in Glomerular Disease	17
Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2	16
Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2	16
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab	16
Single-Nephron GFR in Patients With Obesity-Related Glomerulopathy	16
The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes	16
Nicotinamide Adenine Dinucleotide Biosynthetic Impairment and Urinary Metabolomic Alterations Observed in Hospitalized Adults With COVID-19–Related Acute Kidney Injury	16
The Rational Use of Complement Inhibitors in Kidney Diseases	16
Outcome and Determinants of Outcome of COVID-19 Infection Among Hemodialysis Patients: Findings From a National Dialysis Network Program in India	16
The Proximal Tubule Toxicity of Immunoglobulin Light Chains	16
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations	16
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy	16
Hierarchical Clustering Analysis for Predicting 1-Year Mortality After Starting Hemodialysis	16
Incremental and Personalized Hemodialysis Start: A New Standard of Care	16
Systematic Review of Risk factors and Incidence of Acute Kidney Injury Among Patients Treated with CAR-T Cell Therapies	16
Survey of Telemedicine by Pediatric Nephrologists During the COVID-19 Pandemic	16
Glomerular Classification Using Convolutional Neural Networks Based on Defined Annotation Criteria and Concordance Evaluation Among Clinicians	15
Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases	15
Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists	15
Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis	15
Recalibration of the Renal Angina Index for Pediatric Septic Shock	15
Social Deprivation Is Associated With Lower Access to Pre-emptive Kidney Transplantation and More Urgent-Start Dialysis in the Pediatric Population	15
Performance of Predictive Equations and Biochemical Measures Quantifying Net Endogenous Acid Production and the Potential Renal Acid Load	15
A Systematic Study of the Prevalence and Risk Factors of CKD in Uddanam, India	15
Tolvaptan in ADPKD Patients With Very Low Kidney Function	15
Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients	15
Telemedicine for Outpatient Care of Kidney Transplant and CKD Patients	15
Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the United States	15
Vascular Calcification Slows But Does Not Regress After Kidney Transplantation	15
Incremental Versus Standard (Full-Dose) Peritoneal Dialysis	15
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study	15
IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank	15
COVID-19−Associated Decline in the Size of the End-Stage Kidney Disease Population in the United States	15
Use of Urine Electrolytes and Urine Osmolality in the Clinical Diagnosis of Fluid, Electrolytes, and Acid-Base Disorders	15
Evaluation of Kidney Histological Images Using Unsupervised Deep Learning	15
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy	15
Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Tria	15
Peritoneal Dialysis for Acute Kidney Injury During the COVID-19 Pandemic in New York City	15
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial De	14
A Newly Recognized Endemic Region of CKD of Undetermined Etiology (CKDu) in South India—“Tondaimandalam Nephropathy”	14
Serum Uric Acid and Mortality Risk Among Hemodialysis Patients	14
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1	14
Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis	14
Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing	14
Glomerular Complement Factor H–Related Protein 5 is Associated with Histologic Injury in Immunoglobulin A Nephropathy	14
Efficacy and Safety of Dapagliflozin in Children With Inherited Proteinuric Kidney Disease: A Pilot Study	14
Anticancer Drug-Induced Capillary Leak Syndrome	14
Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism	14
Complement Pathways in Membranous Nephropathy: Complex and Multifactorial	14
Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection	14
A Systematic Review of Renal Pathology in Chronic Kidney Disease of Uncertain Etiology	14
Clinicopathologic Features of Mitochondrial Nephropathy	14
Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation	14
Development and External Validation of a Machine Learning Model for Progression of CKD	14
Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study	14
Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation	14
Creatinine Fluctuations Forecast Cross-Harvest Kidney Function Decline Among Sugarcane Workers in Guatemala	13
Iron Deficiency in CKD Without Concomitant Anemia	13
Blood Transfusion and Adverse Graft-related Events in Kidney Transplant Patients	13
Comparative Analysis of American Heart Association and European Society of Hypertension Ambulatory Blood Pressure Thresholds for Diagnosing Hypertension in Children	13
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies	13
Autosomal Dominant Tubulointerstitial Kidney Disease—Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease	13
Efficacy of Corticosteroids in Infection-Related Glomerulonephritis–A Randomized Controlled Trial	13
Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation	13
CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer	13
Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis	13
NELL1-Associated Membranous Glomerulopathy After Hematopoietic Stem Cell Transplantation	13
Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial	13
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study	13
Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity	13
N-Acetylcysteine Interference With Creatinine Measurement: An In Vitro Analysis	13
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study	13
Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure	13
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality	13
Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings	13
Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease	13
Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms	13
Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors	13
Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children	13
POS-830 NEFECON FOR THE TREATMENT OF IgA NEPHROPATHY IN PATIENTS AT RISK OF PROGRESSING TO END-STAGE RENAL DISEASE: THE NEFIGARD PHASE 3 TRIAL RESULTS	13
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients	13